Publications
Information about journal articles, updated at 07-06-2026, from platform CIÊNCIAVITAE.
Genomic Pathway Alterations and Their Prognostic Impact in Biliary Tract Cancer: Insights from a Multinational Cohort Treated with Cisplatin, Gemcitabine, and Durvalumab
Chiara Pirrone; Umberto Malapelle; Francesco Pepe; Federica Lo Prinzi; Federico Nichetti; Anna Saborowski; Lorenzo Antonuzzo; et al, European Journal of Cancer. 2025. http://dx.doi.org/10.1016/j.ejca.2025.116035 . 10.1016/j.ejca.2025.116035 . European Journal of Cancer
The role of progesterone in ovarian cancer from pathogenesis to personalized therapy: an updated mini-review
European Journal of Gynaecological Oncology. 2025. http://dx.doi.org/10.22514/ejgo.2025.126 . 10.22514/ejgo.2025.126 . European Journal of Gynaecological Oncology
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index
Mara Persano; Margherita Rimini; Francesca Salani; Federica Lo Prinzi; Federico Nichetti; Anna Saborowski; Lorenzo Antonuzzo; et al, Liver International. 2025. http://dx.doi.org/10.1111/liv.70181 . 10.1111/liv.70181 . Liver International
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study
Margherita Rimini; Lorenzo Fornaro; Federica Lo Prinzi; Mario Domenico Rizzato; Anna Saborowski; Lorenzo Antonuzzo; Federico Rossari; et al, International Journal of Cancer. 2025. http://dx.doi.org/10.1002/ijc.35481 . 10.1002/ijc.35481 . International Journal of Cancer
REAL-WORLD OUTCOMES OF ANTI-EGFR RECHALLENGE GUIDED BY LIQUID BIOPSY IN METASTATIC COLORECTAL CANCER
Ricardo Roque; Rita Antunes Santos; Luis Guilherme Santos; Rita Coelho; Isabel Viera Fernandes; Gonçalo Cunha; Marta Gonçalves; Judy Paulo; Nuno Bonito, GE - Portuguese Journal of Gastroenterology. 2025. http://dx.doi.org/10.1159/000544044 . 10.1159/000544044 . GE - Portuguese Journal of Gastroenterology
Severe Reversible Heart Failure Enhanced by Sorafenib Treatment for Hepatocellular Carcinoma
Luís Guilherme Santos; Ricardo Roque; Rita Antunes Santos; Catarina Neves; Nuno Bonito, Cureus. 2025. http://dx.doi.org/10.7759/cureus.76993 . 10.7759/cureus.76993 . Cureus
Outcomes of Broader Genomic Profiling in Metastatic Colorectal Cancer: A Portuguese Cohort Study
Ricardo Roque; Rita Santos; Luís Guilherme Santos; Rita Coelho; Isabel Fernandes; Gonçalo Cunha; Marta Gonçalves; et al, DNA. 2025. https://doi.org/10.3390/dna5010004 . 10.3390/dna5010004 . DNA
Rare Becomes Rarer: Neuroendocrine Carcinoma of the Cervix With Synchronous Breast, Pancreatic, and Ovarian Metastases
Luís Guilherme Santos; Ricardo Roque; Rita Antunes Santos; Tatiana Pereira; Isabel Pazos, Cureus. 2024. http://dx.doi.org/10.7759/cureus.75144 . 10.7759/cureus.75144 . Cureus
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population
Federica Lo Prinzi; Francesca Salani; Margherita Rimini; Mario Domenico Rizzato; Lorenzo Antonuzzo; Silvia Camera; Tomoyuki Satake; et al, The Oncologist. 2024. http://dx.doi.org/10.1093/oncolo/oyae256 . 10.1093/oncolo/oyae256 . The Oncologist
Menstrual Blood Stem Cells-Derived Exosomes as Promising Therapeutic Tools in Premature Ovarian Insufficiency Induced by Gonadotoxic Systemic Anticancer Treatment
Mariana Robalo Cordeiro; Ricardo Roque; Bárbara Laranjeiro; Carlota Carvalhos; Margarida Figueiredo-Dias, International Journal of Molecular Sciences. 2024. https://doi.org/10.3390/ijms25158468 . 10.3390/ijms25158468 . International Journal of Molecular Sciences
Current Applications and Challenges of Next-Generation Sequencing in Plasma Circulating Tumour DNA of Ovarian Cancer
Ricardo Roque; Ilda Ribeiro; Margarida Dias; Charlie Gourley; Isabel Marques Carreira; Roque Ricardo, Biology. 2024. http://dx.doi.org/10.3390/biology13020088 . 10.3390/biology13020088 . Biology
The impact of CDK4/6 inhibitors on the quality of life of working-age women with metastatic breast cancer: a population-based cohort study from Portugal [version 1; peer review: awaiting peer review]
Ana Caetano; Alda Tavares; Mariana Pires; Cláudia Costa; Joana Monteiro; Ricardo Roque; Rita Santos; et al, 2024. https://f1000research.com/articles/13-75/v1 . 10.12688/f1000research.142460.1 .
Impact of COVID-19 Pandemic on In-Hospital Mortality in Patients Without SARS-CoV-2 Infection in an Internal Medicine Ward of a Tertiary Care Hospital in Portugal
Ramalho, Ana Rita; Mendes, Ana Cristina; Camões, Guilherme; Roque, Ricardo; Moura, Pedro; Mateus-Pinheiro, António; Dias, Adriana; et al, Cureus. 2022. http://dx.doi.org/10.7759/cureus.32059 . 10.7759/cureus.32059 . Cureus
The accuracy of magnetic resonance imaging in predicting the size of pure ductal carcinoma in situ: a systematic review and meta-analysis
Roque, Ricardo; Robalo Cordeiro, Mariana; Armas, Mónica; Caramelo, Francisco; Caseiro-Alves, Filipe; Figueiredo-Dias, Margarida, npj Breast Cancer. 2022. https://doi.org/10.1038/s41523-022-00441-x . 10.1038/s41523-022-00441-x . npj Breast Cancer
Oligosecretory multiple myeloma: a devastating presentation of a difficult diagnosis
Ricardo Roque; Laura Machado; Duarte Flor; Francisca Cunha, BMJ Case Reports. 2021. https://doi.org/10.1136/bcr-2020-240404 . 10.1136/bcr-2020-240404 . BMJ Case Reports
Epithelial-mesenchymal interconversions in ovarian cancer: the levels and functions of E-cadherin in intraabdominal dissemination
Roque, Ricardo; Costa Sousa, Filipa; Figueiredo-Dias, Margarida, Oncology Reviews. 2020. http://dx.doi.org/10.4081/oncol.2020.475 . 10.4081/oncol.2020.475 . Oncology Reviews
5 16 out of 16 Publications
All projects
Information of exclusive responsibility of the researcher 07-06-2026 , from platform CIÊNCIAVITAE.
2025
A phase 3 study of first-line sotorasib, panitumumab, and FOLFIRI versus FOLFIRI with or without bevacizumab-awwb for patients with KRAS G12C–mutated metastatic colorectal cancer (CodeBreaK 301)
NCT06252649
Researcher
2024 - 2025
Outcomes of broader genomic profiling of metastatic colorectal cancer
TI 26/2024
Principal investigator
2023 - 2024
OPAL STUDY: A PAN European Observational Cohort Study Describing Clinical Characteristics, Treatment Patterns and Outcomes in Patients Diagnosed With Hepatocellular Carcinoma (HCC)
D419CR00023
Researcher
AstraZeneca - Produtos Farmacêuticos LDA
2022
Unveiling predictive and prognostic biomarkers in advanced stage ovarian carcinoma using liquid biopsy (bioLOC)
TI 28/2022
PhD Student Fellow
Universidade de Coimbra Instituto de Investigação Clínica e Biomédica de Coimbra
2022 - 2022
PROOF Trial: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations
NCT03773302
Researcher
QED Therapeutics Inc
2022 - 2024
A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unressectable Hepatocellular Carcinoma (STELLAR)
NCT0476340
Researcher
Eisai Corporation of North America
5 6 out of 6 projects
We use cookies to improve your visit to our website.